NEXENTIS TECHNOLOGIES INC. Provision for Loan and Lease Losses
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Provision for Loan and Lease Losses of $116.46 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes
us-gaap:ProvisionForLoanAndLeaseLosses · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for the quarter ending 2021-12-31 was $362.00, a 98.94% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for the quarter ending 2021-09-30 was $128.00, a 132.73% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for the quarter ending 2021-06-30 was -$135.42K, a 208.69% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for the quarter ending 2021-03-31 was $251.40K, a 1351.06% increase year-over-year.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for fiscal 2021 was $116.46K, a 33.91% decline from fiscal 2020.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for fiscal 2020 was $176.22K, a 2766.70% increase from fiscal 2019.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for fiscal 2019 was $6.15K.
- NEXENTIS TECHNOLOGIES INC. provision for loan and lease losses for fiscal 2018 was -$54.83K.
| Period end | Provision for Loan and Lease Losses 3 month | Provision for Loan and Lease Losses 6 month | Provision for Loan and Lease Losses 9 month | Provision for Loan and Lease Losses 12 month |
|---|---|---|---|---|
| 2021-12-31 | $362.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $490.00 derived: sum of 2 quarters · filed 2022-03-31 | -$134.93K derived: sum of 3 quarters · filed 2022-03-31 | $116.46K 10-K · filed 2022-03-31 |
| 2021-09-30 | $128.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$135.30K derived: sum of 2 quarters · filed 2021-11-15 | $116.10K 10-Q · filed 2021-11-15 | $150.34K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-06-30 | -$135.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $115.97K 10-Q · filed 2021-08-16 | $150.21K derived: sum of 3 quarters · filed 2022-03-31 | $150.26K derived: sum of 4 quarters · filed 2022-03-31 |
| 2021-03-31 | $251.40K 10-Q · filed 2021-05-18 | $285.63K derived: sum of 2 quarters · filed 2022-03-31 | $285.69K derived: sum of 3 quarters · filed 2022-03-31 | $410.29K derived: sum of 4 quarters · filed 2022-03-31 |
| 2020-12-31 | $34.23K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $34.29K derived: sum of 2 quarters · filed 2022-03-31 | $158.89K derived: sum of 3 quarters · filed 2022-03-31 | $176.22K 10-K · filed 2022-03-31 |
| 2020-09-30 | $55.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $124.66K derived: sum of 2 quarters · filed 2021-11-15 | $141.98K 10-Q · filed 2021-11-15 | $146.76K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $124.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $141.93K 10-Q · filed 2021-08-16 | $146.70K derived: sum of 3 quarters · filed 2021-08-16 | $146.73K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $17.32K 10-Q · filed 2021-05-18 | $22.10K derived: sum of 2 quarters · filed 2021-05-18 | $22.13K derived: sum of 3 quarters · filed 2021-05-18 | $22.46K derived: sum of 4 quarters · filed 2021-05-18 |
| 2019-12-31 | $4.78K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $4.80K derived: sum of 2 quarters · filed 2021-03-29 | $5.14K derived: sum of 3 quarters · filed 2021-03-29 | $6.15K 10-K · filed 2021-03-29 |
| 2019-09-30 | $28.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $359.00 derived: sum of 2 quarters · filed 2020-11-12 | $1.37K 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $331.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $1.34K 10-Q · filed 2020-08-11 | ||
| 2019-03-31 | $1.01K 10-Q · filed 2020-05-15 | |||
| 2018-12-31 | -$54.83K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |